383.42
+1.63
+(0.43%)
At close: January 17 at 4:00:02 PM EST
386.91
+3.49
+(0.91%)
After hours: January 17 at 7:25:35 PM EST
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 26 | 16 | 30 | 30 |
Avg. Estimate | 3.87 | 2.86 | 12.06 | 13.47 |
Low Estimate | 3.84 | 2.69 | 12.03 | 12.87 |
High Estimate | 3.94 | 3.15 | 12.1 | 13.65 |
Year Ago EPS | 3.46 | 2.5 | 10.6 | 12.06 |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 23 | 13 | 27 | 27 |
Avg. Estimate | 6.36B | 5.7B | 22.52B | 24.4B |
Low Estimate | 6.25B | 5.62B | 22.41B | 24.07B |
High Estimate | 6.47B | 5.78B | 22.63B | 24.74B |
Year Ago Sales | 5.82B | 5.24B | 20.5B | 22.52B |
Sales Growth (year/est) | 9.38% | 8.68% | 9.86% | 8.35% |
Earnings History
Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
---|---|---|---|---|
EPS Est. | 3.27 | 2.36 | 2.79 | 2.77 |
EPS Actual | 3.46 | 2.5 | 2.81 | 2.87 |
Difference | 0.19 | 0.14 | 0.02 | 0.1 |
Surprise % | 5.88% | 6.12% | 0.68% | 3.49% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 3.87 | 2.86 | 12.06 | 13.47 |
7 Days Ago | 3.87 | 2.85 | 12.06 | 13.47 |
30 Days Ago | 3.87 | 2.86 | 12.06 | 13.51 |
60 Days Ago | 3.87 | 2.86 | 12.05 | 13.5 |
90 Days Ago | 3.92 | 2.86 | 12.01 | 13.45 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | -- |
Up Last 30 Days | 2 | 2 | 1 | 1 |
Down Last 7 Days | -- | 1 | -- | 5 |
Down Last 30 Days | 1 | 1 | -- | 8 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
SYK | 11.99% | 14.27% | 13.74% | 11.69% |
S&P 500 | 9.47% | 11.36% | 13.97% | 13.61% |
Upgrades & Downgrades
Reiterates | JMP Securities: Market Perform to Market Perform | 1/7/2025 |
Reiterates | RBC Capital: Outperform to Outperform | 1/7/2025 |
Reiterates | Needham: Buy to Buy | 1/7/2025 |
Maintains | Truist Securities: Hold to Hold | 12/18/2024 |
Maintains | Needham: Buy to Buy | 12/12/2024 |
Maintains | Citigroup: Buy to Buy | 12/11/2024 |
Related Tickers
BSX Boston Scientific Corporation
98.66
+0.50%
MDT Medtronic plc
88.08
+1.06%
ABT Abbott Laboratories
113.48
-0.38%
NARI Inari Medical, Inc.
79.55
+0.19%
EW Edwards Lifesciences Corporation
69.78
-0.11%
ZBH Zimmer Biomet Holdings, Inc.
109.56
+0.57%
DXCM DexCom, Inc.
84.38
-0.54%
GMED Globus Medical, Inc.
90.80
+0.36%
PODD Insulet Corporation
275.81
+1.08%
IRTC iRhythm Technologies, Inc.
108.33
+1.25%